# Sientra (SIEN) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/SIEN
## Company Profile
- Ticker: SIEN
- Exchange: NASDAQ
- Sector: MedTech
- Location: United States
- Tags: MedTech
## Stock Data
- Close: Not available
- Market cap: Not available
## Business Overview
Sientra was a medical aesthetics company focused on breast implants and related surgical products before being acquired. Its story was rooted in device and procedure demand rather than drug development.
## Why The Stock Is Moving

Current closing-price context is not available for SIEN.

## Geographic Base

Sientra was headquartered in the United States and traded on NASDAQ before the acquisition. It sat in medical devices and aesthetics.

## Business Model

The business depended on product sales, surgeon adoption, and procedure volume in aesthetic surgery. Investors historically watched commercialization, litigation or regulatory issues, and margin trends.

## Landscape Position

Sientra was a medtech and aesthetics name, not a biotech developer. Because it has been acquired, it now belongs to the historical healthcare M&A set.

## Future Catalysts

- Sientra’s catalysts are breast-implant and reconstructive-surgery demand, along with operating execution. The company moves on procedural demand and commercial stability.

## Recent News
- 2024-04-02 22:30 EST — [Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction](https://biopharmsignal.com/news/SIEN/sientra-announces-completion-and-winning-bidders-of-its-section-363-sales-auction) — Source: Sientra
- 2024-02-13 13:30 EST — [Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process](https://biopharmsignal.com/news/SIEN/sientra-to-pursue-strategic-sale-of-its-business-through-voluntary-chapter-11-process) — Source: Sientra
- 2023-11-09 21:05 EST — [Sientra Reports Third Quarter Financial and Operational Results](https://biopharmsignal.com/news/SIEN/sientra-reports-third-quarter-financial-and-operational-results) — Source: Sientra
- 2023-11-08 13:35 EST — [Sientra to Present at the Stifel 2023 Healthcare Conference](https://biopharmsignal.com/news/SIEN/sientra-to-present-at-the-stifel-2023-healthcare-conference) — Source: Sientra
- 2023-10-30 21:00 EST — [Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook](https://biopharmsignal.com/news/SIEN/sientra-reports-preliminary-unaudited-third-quarter-2023-financial-results-and-provides-update-on-outlook) — Source: Sientra